Catherine Sbeglia
Associate Editor

Catherine Sbeglia is an Associate Editor in Advantage Business Media's Manufacturing Group. She graduated from The University of Rochester where she studied English and Film & Media Studies. Before joining Advantage Business Media, she served as a staff writer for RB Publishing covering information and document management technologies and the digital workplace. She currently lives in Madison, WI. Having already lived on both coasts, she thought she’d give the middle a try. So far, she likes it very much.

Amid growing pressure by the Trump administration to reduce drug prices for U.S. patients, Merck has announced that the company will not increase the average...
7.20.2018
10:31am
The FDA released the Biosimilars Action Plan (BAP) on Wednesday, which details the key actions the agency is taking to encourage innovation and competition...
7.19.2018
7:00am
Pharmaceutical Processing spoke with Olivier Julé, CEO of Biocellvia about how automated image analysis drastically speeds up drug discovery and development...
7.17.2018
5:00am
Vice President of Strategy at D2 Consulting shares her thoughts on the direction of the pharmaceutical industry in light of the Trump Administration’s proposed...
7.12.2018
5:00am
Pfizer is deferring the price increases to give the president an opportunity to strengthen the healthcare system.
7.11.2018
10:27am
Advertisement
President Trump singles out Pfizer on Twitter after the company increased the cost of 100 drugs.
7.10.2018
9:45am
The Adents Serialization Innovation Summit in Philadelphia brought together industry experts to share the new technologies that are empowering life science...
7.10.2018
5:00am
Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Montgomery County, to North Jersey as part of U.S....
7.6.2018
9:31am
As patients and manufacturers await the Trump administration’s massive cuts to drug prices, Pfizer has raised the prices of 100 of their products as of July 1.
7.3.2018
9:41am
AbbVie issued a statement saying it will appeal a U.S. district ruling ordering it and its partner, Besins Healthcare, to pay $448 million to resolve claims...
7.2.2018
9:39am
The long legal battle, lasting over four years, between Cel-Sci and inVentiv, now known as Syneos Health, has finally come to an end, with Cel-Sci emerging...
6.27.2018
10:03am
The FDA granted priority review to Roche for baloxavir marboxil, their single-dose, oral treatment of uncomplicated influenza.
6.26.2018
9:50am
The FDA approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-...
6.26.2018
5:45am
Advertisement
Boehringer Ingelheim announced a 230 million euro ($269 million) investment into a new Biologicals Development Center (BDC) at the company’s Research and...
6.25.2018
10:00am
CEO of Quantuvis, a healthcare IT company, discusses how better and clearer communication between drug manufacturers and pharmacy benefit managers (PBMs) is a...
6.19.2018
5:30am
Johnson & Johnson will establish an Innovation Lung cancer Center on the university’s campus to facilitate close collaboration between the two entities.
6.7.2018
7:00am
The new drug, developed by Frontier Biotechnologies, is the first long-acting fusion inhibitor for HIV, and is reported to have fewer side effects on the liver...
6.6.2018
10:03am
Mylan and Biocon's Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce the...
6.4.2018
10:58pm
Under the agreement, Shuwen will develop companion diagnostics for Bliss’ oncology drug candidates.
5.30.2018
7:05am
Serious liver enzymes have been observed in some participants, prompting the company to stop the Alzheimer's disease study.
5.18.2018
9:31am
The FDA publicized information on brand-name manufacturers that use what government officials call "gaming tactics" to block cheaper, generic...
5.17.2018
1:00pm
Advertisement
In clinical trials, Lucemyra significantly reduced the severity of withdrawal symptoms compared to placebo.
5.17.2018
9:21am
The FDA approved its first biosimilar of 2018, Pfizer’s epoetin alfa Biosimilar, Retacrit.
5.16.2018
7:00am
After the unveiling of the Trump Administration’s plan to lower the cost of prescription drugs, Health & Human Services Secretary, Alex Azar, provides more...
5.15.2018
8:10am
Increased transparency and competition appear to be at the forefront of the Trump Administration’s new plan to tackle high drug costs.
5.14.2018
9:37am
Takeda will acquire Shire for roughly 46 billion pounds ($62.2 billion) in a deal expected to officially close in the first half of 2019.
5.8.2018
9:30am
Aurobindo, a pharmaceutical manufacturing company headquarter in India, has submitted a bid of roughly $1.6 billion to purchase Novartis's dermatology...
5.7.2018
9:53am
Sandoz, a Novartis division, announced that the FDA issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for its...
5.3.2018
3:31pm
The final day of INTERPHEX brings innovations from Marchesini Group USA, Heat and Control Inc, and BS&B Safety Systems.
4.19.2018
8:55am
On day two of INTERPHEX, CPS technologies, Dow Corning, MilliporeSigma showcase their innovations as part of the new FormulationX.
4.18.2018
10:19am
This minute provides an insight into the products showcased by MG America, Rockwell Automation, Cole-Parmer, and Steris Corporation at Interphex 2018.
4.17.2018
9:04am
World Courier's cell and gene therapy service director discusses the importance of a personalized supply chain in cell and gene therapy and the logistics...
4.5.2018
7:00am
Cincinnati Sub-Zero focuses on the need for drug manufacturer's to utilize stability testing in order to maintain drug quality, safety, and effectiveness...
4.3.2018
3:32pm